Arizona State Retirement System Replimune Group, Inc. Transaction History

Arizona State Retirement System

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$5.01 - $9.46 $60,265 - $113,794	12,029 New	12,029 $108,000
Q2 2023 Aug 01, 2023	SELL	$15.65 - $24.1 $563 - $867	-36 Reduced 0.35%	10,344 $240,000
Q1 2023 Apr 27, 2023	BUY	$17.48 - $29.09 $181,442 - $301,954	10,380 New	10,380 $183,000
Q3 2021 Nov 12, 2021	SELL	$28.98 - $39.54 $164,809 - $224,863	-5,687 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$28.5 - $39.37 $28,585 - $39,488	-1,003 Reduced 14.99%	5,687 $218,000
Q1 2021 May 06, 2021	BUY	$30.22 - $45.57 $5,076 - $7,655	168 Added 2.58%	6,690 $204,000
Q4 2020 Jan 28, 2021	BUY	$23.5 - $52.65 $153,267 - $343,383	6,522 New	6,522 $249,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.